Regeneron’s Antibody Cocktail Authorized for Preventing COVID: Why It’s Not a Big Deal for the Stock
Regeneron Pharmaceuticals(NASDAQ:REGN) recently won an expanded U.S. Emergency Use Authorization for REGEN-COV, its antibody cocktail for COVID-19. In this Motley Fool Live video recorded on August 4, 2021, Motley Fool contributors Keith Speights and Brian…
